Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

FP7

PEACHI

Project reference: 305632
Funded under

Prevention of hepatitis C virus (HCV) and HIV-1 co-infections through induction of potent T cell responses using prime-boost viral vector vaccine regimens

From 2013-02-01 to 2017-01-31, ongoing project

Project details

Total cost:

EUR 5 844 998,64

EU contribution:

EUR 4 388 813

Coordinated in:

United Kingdom

Call for proposal:

FP7-HEALTH-2012-INNOVATION-1See other projects for this call

Funding scheme:

CP-FP - Small or medium-scale focused research project

Objective

Related information

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

EU contribution: EUR 1 870 685


University Offices, Wellington Square
OX1 2JD OXFORD
United Kingdom
Administrative contact: Gill Wells
Tel.: +44 1865 289800
Fax: +44 1865 289801
E-mail

Participants

REITHERA SRL
Italy

EU contribution: EUR 1 645 648


VIA GAETANO SALVATORE 486
80145 Napoli
Italy
Administrative contact: Antonella Folgori
Tel.: +39 06 91329746
Fax: +39 06 97849266
E-mail
BORD OSPIDEIL NAOIMH SHEAMUIS
Ireland

EU contribution: EUR 382 180


JAMES S STREET
8 DUBLIN
Ireland
Administrative contact: Colm Bergin
Tel.: +35314162507
Fax: +35314103416
E-mail
KANTONSSPITAL ST. GALLEN
Switzerland

EU contribution: EUR 490 300


Rorschacherstrasse 95
9007 ST. GALLEN
Switzerland
Administrative contact: Pietro Vernazza
Tel.: +41 71 494 26 32
Fax: +41 71 494 61 14
E-mail
GlaxoSmithKline Biologicals S.A
Belgium
Rue de l’Institut
1330 Rixensart
Belgium
Administrative contact: Philippe Denoel
Tel.: +3226564032
E-mail
Record Number: 106242 / Last updated on: 2015-06-29